======= PPP1R13L ======= == Gene Information == * **Official Symbol**: PPP1R13L * **Official Name**: protein phosphatase 1 regulatory subunit 13 like * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10848|10848]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8WUF5|Q8WUF5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PPP1R13L&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PPP1R13L|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607463|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Regulator that plays a central role in regulation of apoptosis and transcription via its interaction with NF-kappa-B and p53/TP53 proteins. Blocks transcription of HIV-1 virus by inhibiting the action of both NF-kappa-B and SP1. Also inhibits p53/TP53 function, possibly by preventing the association between p53/TP53 and ASPP1 or ASPP2, and therefore suppressing the subsequent activation of apoptosis. {ECO:0000269|PubMed:10336463, ECO:0000269|PubMed:12134007, ECO:0000269|PubMed:12524540, ECO:0000269|PubMed:15489900}. |SH3 1| |Ank 2| |Ank| |SH3 2| |cardiac right ventricle morphogenesis| |embryonic camera-type eye development| |ventricular cardiac muscle tissue development| |intercellular bridge| |cardiac ventricle morphogenesis| |cardiac muscle contraction| |multicellular organism growth| |heart contraction| |post-embryonic development| |hair cycle| |molting cycle| |heart process| |striated muscle contraction| |cardiac chamber morphogenesis| |cardiac ventricle development| |cardiac muscle tissue development| |cardiac chamber development| |regulation of signal transduction by p53 class mediator| |transcription corepressor activity| |heart morphogenesis| |muscle contraction| |striated muscle tissue development| |muscle tissue development| |muscle system process| |cadherin binding| |camera-type eye development| |multicellular organismal homeostasis| |transcription factor binding| |eye development| |visual system development| |sensory system development| |developmental growth| |blood circulation| |growth| |circulatory system process| |embryonic organ development| |heart development| |sensory organ development| |cell junction| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |negative regulation of transcription by RNA polymerase II| |circulatory system development| |apoptotic process| |animal organ morphogenesis| |positive regulation of cell differentiation| |embryo development| |programmed cell death| |identical protein binding| |cell death| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |organic cyclic compound biosynthetic process| |negative regulation of RNA metabolic process| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |cellular nitrogen compound biosynthetic process| |homeostatic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |tissue development| |macromolecule biosynthetic process| |regulation of cell differentiation| |regulation of intracellular signal transduction| |system process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp244|SB743921 0.001μM R05 exp244]]|-2.31| |[[:results:exp464|Calcipotriol 5μM R08 exp464]]|1.96| |[[:results:exp165|RO-3306 3 to 4μM on day4 R04 exp165]]|2.14| ^Gene^Correlation^ |[[:human genes:t:tp53tg3c|TP53TG3C]]|0.415| |[[:human genes:t:tp53tg3b|TP53TG3B]]|0.415| |[[:human genes:t:tp53tg3|TP53TG3]]|0.415| |[[:human genes:c:copa|COPA]]|0.414| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2255 * **Expression level (log2 read counts)**: 3.4 {{:chemogenomics:nalm6 dist.png?nolink |}}